发明授权
US4108853A N,15-Didehydro-15-deoxo-pyrimidino-(4,5-b)rifamycin S 失效
N,15-二氢-15-脱氧嘧啶并(4,5-b)利福霉素S

N,15-Didehydro-15-deoxo-pyrimidino-(4,5-b)rifamycin S
摘要:
The subject compound is prepared by an activated manganese dioxide oxidation of N,15-didehydro-15-deoxo-3,15-epi(methano(imino)rifamycin SV. The new compound has antimicrobial utility.
信息查询
0/0